Evolent Health Inc.

NYSE: EVH · Real-Time Price · USD
9.27
0.45 (5.10%)
At close: Aug 15, 2025, 3:59 PM
9.13
-1.51%
After-hours: Aug 15, 2025, 07:14 PM EDT

Evolent Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-51.09M -64.62M -22.8M -23.14M 1.6M -17.28M -33.41M -25.32M -34.32M -19.98M -11.35M 2.12M -4.59M -5.35M -5.65M -13.04M -9.11M -9.81M
Depreciation & Amortization
23.14M 26.45M 32.98M 29.7M 31.87M 29.5M 29.6M 32.4M 32.13M 31.57M 19.78M 17.2M 15.11M 15.11M 14.91M 14.86M 14.92M 15.35M
Stock-Based Compensation
n/a 11.08M -6.12M 14.42M 12.66M 18.79M 10.6M 10.22M 8.97M 10.71M 14.63M 6.99M 7.01M 5.35M 4.96M 4.39M 3.65M 3.71M
Other Working Capital
-146.08M -10.49M -46.17M 10.65M -73.1M -48.93M 135.41M 76.25M 27.53M -6.25M 78.78M 33.89M -18.67M -90.19M -8.08M -32.53M 34.13M 5.48M
Other Non-Cash Items
57.9M 54.4M 16.06M 5.57M 2.45M 11.89M 52.65M 15.45M 18.79M 32.21M -9.05M -8.69M 2.4M 17.35M 9.23M 7.09M 1.77M -4.33M
Deferred Income Tax
-865K 295K -1.07M -937K -1.16M 354K -19.26M -7.18M -2.29M -68.73M 3.86M -3.99M 604K -132K -238K -20K -209K -59K
Change in Working Capital
-59.41M -23.05M -45.28M -6.94M -26M -38.34M 49.2M 34.94M -22.63M 6.25M 17.83M -25.91M -6.87M -89.77M 43.44M 31.21M -35.27M -53.02M
Operating Cash Flow
-30.33M 4.57M -26.23M 18.67M 21.42M 4.91M 89.38M 60.52M 654K -7.97M 35.7M -3.47M 13.66M -57.44M 66.66M 44.5M -24.25M -48.16M
Capital Expenditures
-8.77M -8.6M -6.15M -6.29M -7.11M -5.35M -6.05M -6.79M -6.84M -9.05M -10.74M -9.87M -9.24M -8.51M -7.24M -6.23M -5.57M -5.94M
Cash Acquisitions
-51.55M n/a -1K 5.95M -4.56M -1.39M n/a n/a -1.52M -386.72M 1.38M -235.95M 1.8M 2.38M -47.12M 4.43M n/a 7.9M
Purchase of Investments
-1M n/a n/a -2.44M -1.88M -3M n/a n/a 1.51M 385.94M 17.74M n/a -17.74M n/a -1K n/a n/a -2.99M
Sales Maturities Of Investments
788K n/a n/a -7K 7K n/a n/a 71K 13K 786K 1.38M n/a 1.8M 2.38M 54.37M 4.85M n/a 500K
Other Investing Acitivies
n/a -4.5M -13.78M -16.94M n/a n/a n/a 577K -1.51M -385.94M -14.21M -240.94M 6.94M 22.9M -54.37M -3.91M n/a 46.49M
Investing Cash Flow
-60.53M -13.09M -19.93M -19.73M -13.54M -9.73M -6.05M -6.14M -8.35M -394.99M -4.46M -254.99M -16.44M 16.77M -54.37M -1.8M -5.57M 45.95M
Debt Repayment
n/a 158.5M 59.1M n/a n/a -529K -25.27M -10M -267K 218.83M n/a 219.74M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -4.59M -310K -692K -364K -14.33M n/a n/a -138K -12.61M -899K -948K -257K -16.21M -453K -255K -455K -2.69M
Dividend Paid
n/a -4.58M -4.81M -5.13M -5.07M -5.08M -5.16M -5.1M -4.88M -3.65M -14.88M n/a -13.78M -1.1M n/a n/a -1.3M n/a
Other Financial Acitivies
-8.93M -41.48M 42.64M -6.22M -98.38M 19.43M -52.98M -20.67M 28.48M -5.03M -10.85M -49.63M 34.47M -50.28M 61.35M 641K -34.2M -55.58M
Financial Cash Flow
-8.93M 107.85M 96.94M -9.01M -103.38M 14.88M -84.35M -37.37M 23.33M 379.73M -10.85M 173.08M 20.69M -51.38M 60.9M 641K -35.5M -55.58M
Net Cash Flow
-87.42M 99.35M 50.65M -10.1M -95.44M 10.02M -1.04M 16.9M 15.63M -23.19M 20.34M -85.61M 17.65M -92.16M 73.19M 43.34M -65.36M -57.8M
Free Cash Flow
-39.1M -4.03M -32.38M 12.38M 14.31M -438K 83.33M 53.73M -6.19M -17.03M 24.95M -13.34M 4.43M -65.95M 59.41M 38.27M -29.82M -54.1M